Rare diseases
Investigational molecules
Locations
Oberlaaer Strasse 235, Favoriten, 1100 Vienna, Austria
Research activity includes human normal immunoglobulin therapies for patients with weakened immune function, with attention to preventing serious bacterial and major infections in settings such as hypogammaglobulinemia and secondary immunodeficiency.
These studies extend to patients receiving B-cell depletion therapy and those with immune dysfunction linked to chronic lymphocytic leukemia.
Octapharma Pharmazeutika Produktionsgesellschaft mbH runs clinical trials in conditions such as Hereditary angioedema with C1 esterase inhibitor deficiency, Hereditary angioedema, Infection prophylaxis, Chronic lymphocytic leukaemia, among others.
Clinical trials run by this sponsor – those enrolling participants first.
BulgariaBulgaria
Czechia
Italy
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
